Draft policy on publication and access to clinical-trial data: one month left to send comments
The public consultation on the European Medicines Agency’s draft policy on publication and access to clinical-trial data ends on 30 September 2013.
Stakeholders have one more month to send their comments on the draft policy to the Agency.
Comments should be made using the submission form and sent no later than 30 September 2013 to email@example.com.
The draft policy outlines the rules for the publication and access to data from clinical trials submitted as part of a marketing-authorisation application, once the decision-making process has ended.
- Release of data from clinical trials
- European Medicines Agency releases for public consultation its draft policy on the publication and access to clinical-trial data (24/06/2013)